The use of CI-994 and dinaline for the treatment of memory/cognition and anxiety disorders

Details for Australian Patent Application No. 2010313255 (hide)

Owner The General Hospital Corporation D/ B/A Massachusetts General Hospital The Broad Institute, Inc. Massachusetts Institute of Technology

Inventors Tsai, Li-Huei; Guan, Ji-Song; Haggarty, Stephen J.; Holson, Edward; Wagner, Florence; Graeff, Johannes

Agent Pizzeys

Pub. Number AU-A-2010313255

PCT Pub. Number WO2011/053876

Priority 61/265,468 01.12.09 US; 61/256,927 30.10.09 US

Filing date 29 October 2010

Wipo publication date 5 May 2011

International Classifications

A01N 37/12 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids - containing the group , wherein C means a carbon skeleton not containing a ring

A61K 31/195 (2006.01)

Event Publications

31 May 2012 PCT application entered the National Phase

  PCT publication WO2011/053876 Priority application(s): WO2011/053876

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010313273-Methods of treating viral associated diseases

2010313253-Dimethyl sulfoxide (DMSO) and methylsulfonylmethane (MSM) formulations to treat osteoarthritis